Centerpoint Advisors’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Hold
2,500
﹤0.01% 305
2026
Q1
$15K Hold
2,500
﹤0.01% 286
2025
Q4
$18K Hold
2,500
0.01% 269
2025
Q3
$19K Sell
2,500
-2,500
-50% -$18.2K 0.01% 260
2025
Q2
$31K Hold
5,000
0.01% 188
2025
Q1
$16K Hold
5,000
0.01% 271
2024
Q4
$20K Hold
5,000
0.01% 266
2024
Q3
$20K Hold
5,000
0.01% 271
2024
Q2
$13K Hold
5,000
﹤0.01% 326
2024
Q1
$22K Hold
5,000
0.01% 231
2023
Q4
$24K Hold
5,000
0.01% 206
2023
Q3
$24K Hold
5,000
0.01% 209
2023
Q2
$30K Hold
5,000
0.01% 201
2023
Q1
$16K Hold
5,000
0.01% 298
2022
Q4
$13K Hold
5,000
0.01% 277
2022
Q3
$11K Hold
5,000
0.01% 215
2022
Q2
$13K Buy
+5,000
New +$13.3K 0.01% 213

Other funds holding EVLV

Centerpoint Advisors's EVLV Position: Q2 2026 in Review

Centerpoint Advisors held its Evolv Technologies (EVLV) position steady in Q2 2026 at 2,500 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Centerpoint Advisors first reported a position in EVLV in Q2 2022 and has held it in 17 quarters since. The position peaked at $31K in Q2 2025. 261 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

  • Centerpoint Advisors held 2,500 shares of Evolv Technologies worth $15K as of Q2 2026.
  • Centerpoint Advisors left its Evolv Technologies share count unchanged in Q2 2026.
  • Evolv Technologies made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #305 holding.
  • Centerpoint Advisors first reported a position in Evolv Technologies in Q2 2022 and has held it in 17 quarters since.
  • Centerpoint Advisors's Evolv Technologies position peaked at $31K in Q2 2025.
  • 261 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.